Associate Professor Leo Davies

MD, FRACP
Conjoint Associate Professor, Sydney Medical School
Associate Dean (Evaluation & Assessment), Sydney Medical Program
Senior Staff Specialist in Neurology & Head, Department of Neurophysiology, Royal Prince Alfred Hospital

Telephone +61 2 9515 7565
Fax +61 2 9515 7564

Map

Biographical details

Associate Professor Leo Davies is a neurologist with clinical and research interests in movement disorders and stroke, and a strong interest in medical education and assessment. He has previously worked as a Clinical and Research Fellow at Harvard University, studying the physiology of human movement. Associate Professor Davies says, “alongside movement disorders, I developed an interest in stroke because as our population ages, in-hospital neurology practice is dominated by this disease. It is an area where research and evidence-based management can make a real difference toward reducing disease burden in the community”. Associate Professor Davies also is actively involved in medical education and assessment. He is the past Chairman of the RACP Clinical Examinations Committee, current member of the National Examination Panel, and oversees the assessment of medical students in the Sydney Medical Program. He notes, “assessment necessitates balancing our demand for excellence, the community’s need for safe practitioners and the load imposed on students. Since student learning is strongly influenced by assessment, we need processes that ensure students are trained in a manner that serves the needs of the community”. Associate Professor Davies has helped implement reliable, robust student assessments that reduce bias and promote the development of skilled medical practitioners. He is Chairman of the Australian Medical Schools Assessment Collaboration (AMSAC) through which he has led a series of Benchmarking projects. He is a member of the Medical Deans of Australia and New Zealand Assessment Collaboration Steering Committee.

Research interests

Associate Professor Davies conducts research on stroke, movement disorders and peripheral neuropathy. He is involved in a number of clinical trials in stroke including the ENCHANTED study, which aims to fine-tune the management of patients eligible for thrombolysis in acute ischaemic stroke. He also is testing therapies for autoimmune neurological disorders.

Associate Professor Davies also conducts research relating to medical education and medical student assessment. He notes, “medical schools clearly will have differing assessment processes. The important question is: how do we decide what is a satisfactory standard?” As Chairman of AMSAC, he oversees a benchmarking process in which medical schools share assessment materials delivered to students at the mid-point of their medical degrees. As a member of the Medical Deans of Australia and New Zealand Assessment Collaboration Steering Committee, he is working to help develop a national approach to benchmarking medical school assessment and graduate outcomes, which will involve all Australian and New Zealand medical schools.

Keywords

Stroke; Education; Assessment; Benchmarking

Clinical Specialty

Neurology

Selected publications

Download citations: PDF RTF Endnote

Journals

  • O'Mara, D., Quinnell, R., Rothnie, I., Davies, L., Pye, M. (2014). ExamBank: a Pedagogic and Administrative System to Provide Effective Student Feedback and Stable Assessment Across Disciplines. International Journal of Innovation in Science and Mathematics Education, 22(3), 62-73.
  • Hardy, T., Barnett, M., Mohamed, A., Garsia, R., Davies, L. (2012). Severe Bickerstaffs encephalitis treated with Rituximab: Serum and CSF GQ1b antibodies. Journal of Neuroimmunology, 251(1/2), 107-109. [More Information]
  • Barnett, M., Chohan, G., Davies, L. (2011). Blurred vision and pain in the eye. Medical Journal of Australia, 195(6), 329-332. [More Information]
  • Ahmed, R., Buckland, M., Davies, L., Halmagyi, G., Rogers, S., Oberste, M., Barnett, M. (2011). Enterovirus 71 meningoencephalitis complicating rituximab therapy. Journal of the Neurological Sciences, 305(1-2), 149-151. [More Information]
  • Davies, L., Anderson, C. (2011). Practical neurology: a case-based series. Medical Journal of Australia, 195(6), 328-328. [More Information]
  • Turner-Stokes, L., Baguley, I., de Graaff, S., Katrak, P., Davies, L., McCrory, P., Hughes, A. (2010). Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial. Journal of Rehabilitation Medicine, 42(1), 81-89. [More Information]
  • McCrory, P., Turner-Stokes, L., Baguley, I., de Graaff, S., Katrak, P., Sandanam, J., Davies, L., Munns, M., Hughes, A. (2009). Botulinum toxin a for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. Journal of Rehabilitation Medicine, 41(7), 536-544. [More Information]
  • Kirk, E., Malaty-Brevaud, V., Martini, N., Lacoste, C., Levy, N., Maclean, K., Davies, L., Philip, N., Badens, C. (2008). The clinical variability of the MECP2 duplication syndrome: description of two families with duplications excluding L1CAM and FLNA. Clinical Genetics, 75, 301-3. [More Information]
  • McDougall, A., Davies, L., McCaughan, G. (2003). Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle and Nerve, 28(5), 595-600. [More Information]
  • Cordato, N., Halliday, G., McCann, H., Davies, L., Williamson, P., Fulham, M., Morris, J. (2001). Corticobasal syndrome with tau pathology. Movement Disorders, 16, 656-667.
  • Barnett, B., Prosser, J., Sutton, I., Halmagyi, G., Davies, L., Harper, C., Dalmau,, J. (2001). Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. Journal of Neurology, Neurosurgery and Psychiatry, 70, 222-225.
  • Cremer, P., Migliaccio, A., Pohl, D., Curthoys, I., Davies, L., Yavor, R., Halmagyi, G. (2000). Posterior semicircular canal nystagmus is conjugate and its axis is parallel to that of the canal. Neurology, 54, 2016-2020.

2014

  • O'Mara, D., Quinnell, R., Rothnie, I., Davies, L., Pye, M. (2014). ExamBank: a Pedagogic and Administrative System to Provide Effective Student Feedback and Stable Assessment Across Disciplines. International Journal of Innovation in Science and Mathematics Education, 22(3), 62-73.

2012

  • Hardy, T., Barnett, M., Mohamed, A., Garsia, R., Davies, L. (2012). Severe Bickerstaffs encephalitis treated with Rituximab: Serum and CSF GQ1b antibodies. Journal of Neuroimmunology, 251(1/2), 107-109. [More Information]

2011

  • Barnett, M., Chohan, G., Davies, L. (2011). Blurred vision and pain in the eye. Medical Journal of Australia, 195(6), 329-332. [More Information]
  • Ahmed, R., Buckland, M., Davies, L., Halmagyi, G., Rogers, S., Oberste, M., Barnett, M. (2011). Enterovirus 71 meningoencephalitis complicating rituximab therapy. Journal of the Neurological Sciences, 305(1-2), 149-151. [More Information]
  • Davies, L., Anderson, C. (2011). Practical neurology: a case-based series. Medical Journal of Australia, 195(6), 328-328. [More Information]

2010

  • Turner-Stokes, L., Baguley, I., de Graaff, S., Katrak, P., Davies, L., McCrory, P., Hughes, A. (2010). Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial. Journal of Rehabilitation Medicine, 42(1), 81-89. [More Information]

2009

  • McCrory, P., Turner-Stokes, L., Baguley, I., de Graaff, S., Katrak, P., Sandanam, J., Davies, L., Munns, M., Hughes, A. (2009). Botulinum toxin a for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. Journal of Rehabilitation Medicine, 41(7), 536-544. [More Information]

2008

  • Kirk, E., Malaty-Brevaud, V., Martini, N., Lacoste, C., Levy, N., Maclean, K., Davies, L., Philip, N., Badens, C. (2008). The clinical variability of the MECP2 duplication syndrome: description of two families with duplications excluding L1CAM and FLNA. Clinical Genetics, 75, 301-3. [More Information]

2003

  • McDougall, A., Davies, L., McCaughan, G. (2003). Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle and Nerve, 28(5), 595-600. [More Information]

2001

  • Cordato, N., Halliday, G., McCann, H., Davies, L., Williamson, P., Fulham, M., Morris, J. (2001). Corticobasal syndrome with tau pathology. Movement Disorders, 16, 656-667.
  • Barnett, B., Prosser, J., Sutton, I., Halmagyi, G., Davies, L., Harper, C., Dalmau,, J. (2001). Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. Journal of Neurology, Neurosurgery and Psychiatry, 70, 222-225.

2000

  • Cremer, P., Migliaccio, A., Pohl, D., Curthoys, I., Davies, L., Yavor, R., Halmagyi, G. (2000). Posterior semicircular canal nystagmus is conjugate and its axis is parallel to that of the canal. Neurology, 54, 2016-2020.

To update your profile click here. For support on your academic profile contact .